Get Personalized Help, Administration Info & More | STELARA® (ustekinumab)

Personalized help every step of the way

Receive personal support from a registered nurse (a real person!) for every step of your STELARA® treatment.

It’s the Nurse Navigator program, and it’s easy and free to enroll. After you sign up, your Nurse Navigator will contact you within 24 hours.

Your Nurse Navigator can help you with:

Providing hands-on
treatment education

Scheduling your
one-time IV infusion

Arranging for in-person
self-injection training

Connecting you to a specialist for cost and insurance coverage support

The nurse program is limited to education about your Janssen medication, its administration, and/or the condition it treats. It is not intended to provide medical advice, replace a treatment plan you receive from your doctor or nurse, or serve as a reason for you to start or stay on treatment.

Hear from a patient

Infusion & injection dosing information

Start with a
one-time IV infusion

STELARA® treatment starts with a one-time intravenous (IV) infusion through a vein in the arm that provides the amount of medication based on your body weight and is administered by a medical professional in a comfortable setting. It takes at least 1 hour to receive the full dose of medicine.

Keep going with
maintenance injections

After the one-time IV infusion, you will receive STELARA® as an injection under the skin (subcutaneous injection) every 8 weeks. There are 6 injections during the first year of treatment. Your doctor can administer at his or her office, or your doctor will decide if you or a caregiver may give your injections of STELARA® at home.

STELARA® is intended for use under the guidance and supervision of your doctor. If your doctor decides that you or a caregiver may give your injections of STELARA® at home, you should receive training on the right way to prepare and inject STELARA®.

The following video will provide an overview of self-injecting. Also be sure to thoroughly read the Medication Guide and Instructions for Use prior to injecting.

If you or your caregiver will be administering your STELARA® maintenance doses at home, you can get additional in-person injection training and support through your Nurse Navigator.

Lasting remission can start with STELARA®

Clinical trials included patients who failed or were intolerant to other medications, including a biologic, prior to STELARA®. After only one intravenous (IV) infusion of STELARA®, the majority of patients saw rapid relief from their UC symptoms in just 8 weeks, with nearly 1 in 5 achieving remission. 4 out of 10 patients were in remission at year 1 after responding to the IV induction dose and continuing treatment with STELARA®. Nearly 7 out of 10 patients had no rectal bleeding at all and also had fewer daily bowel movements at ~2 years.*

Individual results may vary. STELARA® is not for everyone. 
Only you and your doctor can decide if STELARA® is right for you.


Ask your doctor about the benefits and risks of STELARA®. Prescription medications, including STELARA®, have possible risks involved with treatment, so it’s important to discuss them with your doctor.

STELARA® is not for everyone; only your doctor can decide if it's right for you. STELARA® is a prescription medicine that affects your immune system. It can increase your chance of having serious side effects including serious infections, cancer, serious allergic reactions, lung inflammation, and a rare condition called posterior reversible encephalopathy syndrome.

These are not all the possible side effects of STELARA®.

Please read the Important Safety Information located at the bottom of the screen and the Medication Guide for STELARA® to learn more about these and other risks for STELARA®. Discuss any questions you have with your doctor.

In clinical studies, the most common side effects were:

  • nasal congestion, sore throat, and runny nose
  • upper respiratory infections
  • fever
  • headache
  • tiredness
  • itching
  • nausea and vomiting
  • redness at the injection site
  • vaginal yeast infections
  • urinary tract infections
  • sinus infection
  • bronchitis
  • diarrhea
  • stomach pain
  • joint pain

These are not all of the possible side effects of STELARA®. Call your doctor for medical advice about side effects.

You should not receive a live vaccine while taking STELARA®. Before receiving STELARA®, tell your doctor if you have recently received or are scheduled to receive an immunization (vaccine). Tell your doctor if anyone in your house needs a vaccine. The viruses used in some types of vaccines can spread to people with a weakened immune system, and can cause serious problems. You should not receive the BCG vaccine during the one year before taking STELARA® or one year after you stop taking STELARA®.

Once you and your doctor have decided STELARA® is right for you, Janssen CarePath will help you find the resources you may need to get started and stay on track. We will give you information on your insurance coverage, potential out-of-pocket costs, and treatment support, and identify options that may help make your treatment more affordable.

Support Options for Commercially Insured Patients

Janssen CarePath 
Savings Program

If you have commercial insurance and your insurance coverage for STELARA® is approved

Check your eligibility and enroll at

Janssen Link

If your commercial insurance coverage is delayed (>5 business days) or denied

Both the Janssen CarePath Savings Program and the Janssen Link program are unavailable to individuals who use any state or federal government-funded healthcare program to cover a portion of medication costs, such as Medicare, Medicaid, TRICARE, Department of Defense, or Veterans Administration. These programs are for medication only. Terms expire at the end of each program year and may change.

Personalized Help with STELARA® (ustekinumab)